SDMA (p-hydroxyazobenzene-p′-sulfonate)

Overview

SDMA p-hydroxyazobenzene-p′-sulfonate is the p-hydroxyazobenzene-p′-sulfonate salt form of SDMA ( HY-101410 ). SDMA p-hydroxyazobenzene-p′-sulfonate is an endogenous inhibitor of nitric oxide synthase ( NO synthase ) activity. SDMA p-hydroxyazobenzene-p′-sulfonate is an activator for NF-κB , and promotes the expression of IL-6 and TNF-α. SDMA p-hydroxyazobenzene-p′-sulfonate is stable in serum and plasma, and can be used as a kidney biomarker of hepatic and renal dysfunction.

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > NF-κB | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Endogenous Metabolite | Products > Signaling Pathways > NO Synthase | Products > Signaling Pathways > NF-κB

Product Information

• Catalog No.: HY-101410A
• CAS No.: 1266235-58-8
• Molecular Formula: C12H10N2O4S·1/2C8H18N4O2
• Molecular Weight: 378.41
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source